Breaking News Instant updates and real-time market news.

NXPI

NXP Semiconductors

$114.17

-1.71 (-1.48%)

, KR

Kroger

$23.60

0.12 (0.51%)

07:30
04/13/18
04/13
07:30
04/13/18
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Thursday in NXP Semiconductors (NXPI), Kroger (KR), AveXis (AVXS), First Horizon (FHN), Banc of California (BANC), and Healthcare Services (HCSG).

NXPI

NXP Semiconductors

$114.17

-1.71 (-1.48%)

KR

Kroger

$23.60

0.12 (0.51%)

AVXS

AveXis

$212.39

0.54 (0.25%)

FHN

First Horizon

$19.00

0.25 (1.33%)

BANC

Banc of California

$18.80

0.05 (0.27%)

HCSG

Healthcare Services

$42.32

0.44 (1.05%)

  • 13

    Apr

  • 03

    May

  • 10

    May

  • 14

    May

  • 21

    May

  • 05

    Jun

NXPI NXP Semiconductors
$114.17

-1.71 (-1.48%)

04/12/18
SBSH
04/12/18
INITIATION
Target $58
SBSH
Neutral
Qualcomm resumed with a Neutral at Citi
Citi analyst Christopher Danely resumed coverage of Qualcomm (QCOM) with a Neutral rating and $58 price target. The analyst believes the proposed acquisition of NXP Semiconductors (NXPI) could eventually drive earnings accretion of roughly 44% or $1.52, but he does not have confidence in the $500M in synergies. Danely expects a host of integration difficulties given differences in manufacturing, customer base, and NXP's merger with Freescale.
04/12/18
SBSH
04/12/18
INITIATION
Target $127.5
SBSH
Neutral
NXP Semiconductors resumed with a Neutral at Citi
Citi analyst Christopher Danely resumed coverage of NXP Semiconductors (NXPI) with a Neutral rating and $127.50 price target. The analyst expects Qualcomm (QCOM) to close the acquisition of NXP at the current proposed price of $127.50 per share. He believes, however, that there is "some potential for the deal to break due to approval from China given the trade war." If the deal falls apart, Danely expects NXP shares to trade to $90.
03/19/18
MSCO
03/19/18
INITIATION
Target $127.5
MSCO
Equal Weight
NXP Semiconductors reinitiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Craig Hettenbach resumed coverage on NXP Semiconductors (NXPI) with an Equal Weight and $127.50 price target.
03/15/18
DBAB
03/15/18
INITIATION
Target $60
DBAB
Hold
Qualcomm resumed with a Hold at Deutsche Bank
Deutsche Bank analyst Ross Seymore resumed coverage of Qualcomm (QCOM) with a Hold rating and $60 price target. The analyst expects the shares to remain range-bound given the slowing pace of smartphone growth, potential for share loss in QCT, and ongoing litigation pressuring the QTL business. He sees these partially offset by accretion from the acquisition of NXP Semiconductors (NXPI).
KR Kroger
$23.60

0.12 (0.51%)

03/12/18
JEFF
03/12/18
NO CHANGE
Target $31
JEFF
Buy
Kroger 10% selloff last week overdone, says Jefferies
Jefferies analyst Christopher Mandeville views the 10% selloff last week in shares of Kroger as overdone. The company is making the right moves by pulling forward Restock investment post tax reform to better position it for long-term success, Mandeville tells investors in a research note. The analyst sees an attractive risk/reward for Kroger shares and keeps a Buy rating on the name. He trimmed his price target for the stock to $31 from $33.
03/26/18
LOOP
03/26/18
NO CHANGE
Target $25
LOOP
Hold
Kroger merger with Target 'could make sense', says Loop Capital
Loop Capital analyst Andrew Wolf speculates that while "unlikely" in the near term, a merger between Kroger (KR) and Target (TGT) could make sense. Wolf notes that Kroger has been looking at digital commerce acquisitions and partnerships to maximize its delivery and merchandise, while Target has been an underperformer in the grocery segment. The analyst keeps his Hold rating and $25 price target on Kroger, but adds that its multiple could expand "modestly" as its comps improve this year.
04/09/18
RHCO
04/09/18
NO CHANGE
Target $50
RHCO
Buy
Central Garden & Pet price target raised to $50 from $45 at SunTrust
SunTrust analyst William Chappell raised his price target on Central Garden & Pet (CENT) to $50, saying the company is "better positioned in the pet and garden segments than it has ever been". Chappell attributes his expectations of strong business momentum for the next few years to the margin expansion trends from the operating initiatives taken by the new management, the company's increasing focus on private label distribution growth, the expansion into Live Pets segment, and February's launch of a partnership with Kroger (KR). The analyst keeps his Buy rating on Central Garden & Pet.
04/13/18
OPCO
04/13/18
NO CHANGE
OPCO
Outperform
Low levels of food inflation to keep weighing on grocery names, Oppenheimer says
Following a government report this week that showed another month of soft food inflation data, Oppenheimer analyst Rupesh Parikh said he expects low food inflation to continue to weigh on grocery names, taking a "subdued" view into earnings for pure-play grocery names like Kroger (KR), National Grocers (NGVC), Sprouts Farmers Market (SFM) and Smart & Final Stores (SFS). Parikh's top picks across the broader grocery/discounter space remain Dollar General (DG) and Dollar Tree (DLTR), followed by Sprouts, he said. The analyst has an Outperform rating on Dollar General, Dollar Tree and Sprouts, and a Perform rating on Kroger, Natural Grocers, Smart & Final Stores and United Natural Foods (UNFI).
AVXS AveXis
$212.39

0.54 (0.25%)

04/12/18
UBSW
04/12/18
DOWNGRADE
Target $218
UBSW
Neutral
AveXis downgraded to Neutral from Buy at UBS
UBS analyst Carter Gould downgraded AveXis (AVXS) to Neutral while raising his price target for the shares to $218 from $143. The analyst has confidence the takeover by Novartis (NVS) will close, and notes the shares are within 5% of the $218 offer price. The chance of antitrust concerns arising are remote, Gould tells investors in a research note.
04/12/18
LEHM
04/12/18
DOWNGRADE
Target $218
LEHM
Equal Weight
AveXis downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Gena Wang downgraded AveXis (AVXS) to Equal Weight to reflect the proposed takeover by Novartis (NVS). The analyst sees limited antitrust risks and a low probability of a counterbid. She raised her price target for AveXis shares to $218 from $152. She believes the price being paid by Novartis fully reflects the value of the stock.
04/13/18
CHDN
04/13/18
DOWNGRADE
CHDN
Neutral
AveXis downgraded to Neutral from Buy at Chardan
04/11/18
FBCO
04/11/18
DOWNGRADE
Target $218
FBCO
Neutral
AveXis downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Martin Auster downgraded AveXis (AVXS) to Neutral from Outperform and raised his price target on the shares to $218 from $170 ahead of likely closing of the Novartis (NVS) deal.
FHN First Horizon
$19.00

0.25 (1.33%)

04/09/18
PIPR
04/09/18
INITIATION
Target $22
PIPR
Overweight
First Horizon initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst William Curtiss started First Horizon National with an Overweight rating and $22 price target. The analyst sees acquisition benefits driving the company's profitability. He views the stock's current valuation as attractive.
04/05/18
WELS
04/05/18
UPGRADE
Target $21
WELS
Outperform
First Horizon upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Jared Shaw upgraded First Horizon National to Outperform with an unchanged price target of $21. The company is well positioned to hit the "conservative targets" set for 2018, Shaw tells investors in a research note. He believes the shares should be trading closer to the group and expects the valuation gap to narrow.
03/22/18
UBSW
03/22/18
INITIATION
Target $25
UBSW
Buy
First Horizon initiated with a Buy at UBS
UBS analyst Brock Vandervliet started First Horizon with a Buy rating and $25 price target. The analyst rolled out coverage last night on the Mid-Cap Banks. He sees performance differentiation "playing out more starkly" than investors may expect with "increasingly advantaged and disadvantaged participants."
02/09/18
LEHM
02/09/18
UPGRADE
Target $23
LEHM
Overweight
First Horizon upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Matthew Keating upgraded First Horizon National to Overweight with an unchanged price target of $23. The analyst sees favorable consensus earnings revisions as the company executes on the cost savings embedded in its Capital Bank Financial acquisition. Further, he notes the shares at a discounted multiple despite First Horizon's above-average profitability and core earnings growth trends.
BANC Banc of California
$18.80

0.05 (0.27%)

02/01/18
RILY
02/01/18
DOWNGRADE
Target $20
RILY
Neutral
Banc of California downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst Stephen Moss downgraded Banc of California to Neutral and lowered his price target for the shares to $20 from $25. The analyst says expectations for better earnings results are delayed following the company's Q4 results.
04/06/18
BOFA
04/06/18
DOWNGRADE
BOFA
Underperform
Banc of California downgraded to Underperform from Neutral at BofA/Merrill
04/06/18
BOFA
04/06/18
DOWNGRADE
Target $19
BOFA
Underperform
Banc of California downgraded to Underperform at BofA/Merrill
As previously reported, BofA/Merrill downgraded Banc of California to Underperform from Neutral and cut its price target to $19 from $22. Analyst Ebrahim Poonwala said the company's new management team is working towards achieving its long-term strategic targets but is cautious on elevated execution risk given the balance sheet overhaul and lower quality deposit base.
04/06/18
04/06/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Incyte (INCY) downgraded to Neutral from Buy at Guggenheim and to Market Perform from Outperform at William Blair. 2. Ormat Technologies (ORA) downgraded to Perform from Outperform at Oppenheimer with analyst Noah Kaye citing valuation. 3. Sprague Resources (SRLP) downgraded to Underweight from Neutral at JPMorgan with analyst Andrew Burd citing the stock's year-to-date outperformance for the downgrade. 4. Banc of California (BANC) downgraded to Underperform from Neutral at BofA/Merrill with analyst Ebrahim Poonwala saying the company's new management team is working towards achieving its long-term strategic targets but is cautious on elevated execution risk given the balance sheet overhaul and lower quality deposit base. 5. Xilinx (XLNX) downgraded to Underweight from Neutral at JPMorgan with analyst Harlan Sur saying he believes multiple compression is likely with basestation deployment in China likely to decline in 2018. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
HCSG Healthcare Services
$42.32

0.44 (1.05%)

02/07/18
BARD
02/07/18
DOWNGRADE
Target $50
BARD
Neutral
Healthcare Services downgraded to Neutral at Baird
As previously reported, Baird analyst Andrew Wittmann downgraded Healthcare Services to Neutral from Outperform following in-line Q4 earnings. The analyst sees subdued revenue growth and a period of digestion as management turns its focus to execution. Wittmann believes Healthcare Services shares are fully valued at current levels and lowered his price target to on the stock to $50 from $58.
02/07/18
SIDC
02/07/18
UPGRADE
SIDC
Buy
Healthcare Services upgraded to Buy from Neutral at Sidoti
03/05/18
03/05/18
NO CHANGE

Pacific Square raises risk rating on Healthcare Services
Pacific Square Research increased its risk rating on Healthcare Services Group to an "orange flag" from a "yellow flag," sources tell The Fly. The firm noted that the company's earnings and gross margin would have been considerably lower this quarter without the reversing of an insurance reserve.
02/07/18
BARD
02/07/18
DOWNGRADE
BARD
Neutral
Healthcare Services downgraded to Neutral from Outperform at Baird

TODAY'S FREE FLY STORIES

09:30
10/17/18
10/17
09:30
10/17/18
09:30
General news
The September housing report was disappointing »

The September housing…

NFLX

Netflix

09:28
10/17/18
10/17
09:28
10/17/18
09:28
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

TPR

Tapestry

$44.48

1.39 (3.23%)

09:27
10/17/18
10/17
09:27
10/17/18
09:27
Upgrade
Tapestry rating change  »

Tapestry upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NFLX

Netflix

$346.40

13.29 (3.99%)

09:26
10/17/18
10/17
09:26
10/17/18
09:26
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PVTL

Pivotal Software

$19.94

1.44 (7.78%)

09:25
10/17/18
10/17
09:25
10/17/18
09:25
Hot Stocks
Pivotal Software weakness attributed to lock-up expiration »

Shares of Pivotal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$158.81

5.25 (3.42%)

09:25
10/17/18
10/17
09:25
10/17/18
09:25
Periodicals
Facebook Watch lands The Real World from MTV, Deadline reports »

Facebook Watch will now…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

COOP

Mr. Cooper

$15.22

-0.39 (-2.50%)

09:24
10/17/18
10/17
09:24
10/17/18
09:24
Recommendations
Mr. Cooper analyst commentary  »

Mr. Cooper price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSX

Diana Shipping

$3.95

0.07 (1.80%)

, GLNCY

Glencore

$0.00

(0.00%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Hot Stocks
Diana Shipping reports continuation of time charter contract with Glencore »

Diana Shipping (DSX)…

DSX

Diana Shipping

$3.95

0.07 (1.80%)

GLNCY

Glencore

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEON

Neonode

$2.90

0.355 (13.95%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Hot Stocks
Neonode regains compliance with Nasdaq minimum bid price requirement »

Neonode received a letter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$2.89

0.195 (7.25%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Hot Stocks
Kadmon announces FDA breakthrough therapy designation granted to KD025 »

Kadmon announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$145.02

3.9 (2.76%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Recommendations
IBM analyst commentary  »

IBM price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

GPN

Global Payments

$119.87

4.42 (3.83%)

09:22
10/17/18
10/17
09:22
10/17/18
09:22
Recommendations
Global Payments analyst commentary  »

Global Payments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 30

    Oct

HD

Home Depot

$193.61

2.51 (1.31%)

, LOW

Lowe's

$105.97

1.31 (1.25%)

09:21
10/17/18
10/17
09:21
10/17/18
09:21
Downgrade
Home Depot, Lowe's rating change  »

Home Depot, Lowe's…

HD

Home Depot

$193.61

2.51 (1.31%)

LOW

Lowe's

$105.97

1.31 (1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

GWW

Grainger

$280.03

-38.35 (-12.05%)

09:20
10/17/18
10/17
09:20
10/17/18
09:20
Recommendations
Grainger analyst commentary  »

Grainger selloff may be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

HAIR

Restoration Robotics

$1.79

-0.04 (-2.19%)

09:19
10/17/18
10/17
09:19
10/17/18
09:19
Hot Stocks
Restoration Robotics announces results of ARTAS iX case study at ASDS »

Restoration Robotics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

IBM

IBM

$145.02

3.9 (2.76%)

09:18
10/17/18
10/17
09:18
10/17/18
09:18
Technical Analysis
Technical Take: IBM hits fresh 52-week low after earnings disappoint »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
10/17/18
10/17
09:18
10/17/18
09:18
Options
Overnight activity included 287 trades in SPX and 3 trades in VIX »

287 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$18.88

0.76 (4.19%)

09:17
10/17/18
10/17
09:17
10/17/18
09:17
Recommendations
Marvell analyst commentary  »

Marvell management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIFI

Boingo Wireless

$33.43

1.84 (5.82%)

09:17
10/17/18
10/17
09:17
10/17/18
09:17
Recommendations
Boingo Wireless analyst commentary  »

Boingo Wireless price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ABT

Abbott

$70.94

2.22 (3.23%)

09:16
10/17/18
10/17
09:16
10/17/18
09:16
Earnings
Breaking Earnings news story on Abbott »

Abbott sees FY18 sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ABT

Abbott

$70.94

2.22 (3.23%)

09:16
10/17/18
10/17
09:16
10/17/18
09:16
Earnings
Breaking Earnings news story on Abbott »

Abbott sees Q4 sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ODP

Office Depot

$2.85

0.005 (0.18%)

, WPP

WPP

$69.83

0.59 (0.85%)

09:15
10/17/18
10/17
09:15
10/17/18
09:15
Hot Stocks
Office Depot expands marketing agency of record with WPP »

Office Depot (ODP) and…

ODP

Office Depot

$2.85

0.005 (0.18%)

WPP

WPP

$69.83

0.59 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRTEA

Qurate Retail

$21.94

0.32 (1.48%)

09:15
10/17/18
10/17
09:15
10/17/18
09:15
Hot Stocks
Qurate Retail announces long-term iniatitives »

Qurate Retail Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 14

    Nov

CREE

Cree

$37.56

2.53 (7.22%)

09:14
10/17/18
10/17
09:14
10/17/18
09:14
Recommendations
Cree analyst commentary  »

Cree focus on tightening…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGI

Renewable Energy

$29.86

1.31 (4.59%)

09:14
10/17/18
10/17
09:14
10/17/18
09:14
Recommendations
Renewable Energy analyst commentary  »

Renewable Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 14

    Nov

  • 15

    Nov

  • 16

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.